EP 3450460 B1 20230712 - MULTI-SPECIFIC BINDING CONJUGATE, RELATED PHARMACEUTICAL COMPOSITIONS AND USE
Title (en)
MULTI-SPECIFIC BINDING CONJUGATE, RELATED PHARMACEUTICAL COMPOSITIONS AND USE
Title (de)
MULTISPEZIFISCHES BINDUNGSKONJUGAT, ENTSPRECHENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND VERWENDUNG
Title (fr)
CONJUGUÉ DE LIAISON MULTI-SPÉCIFIQUE, COMPOSITIONS PHARMACEUTIQUES ASSOCIÉES ET UTILISATION
Publication
Application
Priority
- CN 2016080749 W 20160429
- CN 2016101984 W 20161013
Abstract (en)
[origin: EP3450460A1] The present invention relates to a multi-specific binding conjugate, a related composition and use. The binding conjugate comprises binding moieties for two or more different receptors, co-receptors, antigens or cellular markers which moieties are coupled by a nanomaterial. The multi-specific binding conjugate can be used to modulate an immune response, treat or prevent a disease or condition (e.g., a cancer, autoimmune disease, pathogen infection or inflammatory disease).
IPC 8 full level
C07K 16/46 (2006.01); A61K 39/44 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); C07K 19/00 (2006.01)
CPC (source: EP)
A61K 39/44 (2013.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); C07K 16/2887 (2013.01); C07K 16/2896 (2013.01); A61K 2039/505 (2013.01); C07K 16/30 (2013.01); C07K 2317/31 (2013.01); C07K 2317/73 (2013.01)
Citation (examination)
WO 2010042562 A2 20100415 - MINERVA BIOTECHNOLOGIES CORP [US], et al
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
EP 3450460 A1 20190306; EP 3450460 A4 20191225; EP 3450460 B1 20230712; EP 3450460 C0 20230712; CN 109195992 A 20190111; EP 4245775 A2 20230920; EP 4245775 A3 20231115; WO 2017185662 A1 20171102
DOCDB simple family (application)
EP 16900170 A 20161013; CN 2016101984 W 20161013; CN 201680085024 A 20161013; EP 23181122 A 20161013